Hutchmed Drc Stock EBITDA
| HCM Stock | USD 18.16 0.83 4.37% |
HUTCHMED DRC fundamentals help investors to digest information that contributes to HUTCHMED DRC's financial success or failures. It also enables traders to predict the movement of HUTCHMED Stock. The fundamental analysis module provides a way to measure HUTCHMED DRC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HUTCHMED DRC stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 25.5 M | 26.8 M |
HUTCHMED | EBITDA |
HUTCHMED DRC Company EBITDA Analysis
HUTCHMED DRC's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current HUTCHMED DRC EBITDA | 25.53 M |
Most of HUTCHMED DRC's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HUTCHMED DRC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
HUTCHMED EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for HUTCHMED DRC is extremely important. It helps to project a fair market value of HUTCHMED Stock properly, considering its historical fundamentals such as EBITDA. Since HUTCHMED DRC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of HUTCHMED DRC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of HUTCHMED DRC's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
HUTCHMED Ebitda
Ebitda |
|
According to the company disclosure, HUTCHMED DRC reported earnings before interest,tax, depreciation and amortization of 25.53 M. This is 97.09% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 99.35% higher than that of the company.
HUTCHMED EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HUTCHMED DRC's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HUTCHMED DRC could also be used in its relative valuation, which is a method of valuing HUTCHMED DRC by comparing valuation metrics of similar companies.HUTCHMED DRC is currently under evaluation in ebitda category among related companies.
HUTCHMED DRC Current Valuation Drivers
We derive many important indicators used in calculating different scores of HUTCHMED DRC from analyzing HUTCHMED DRC's financial statements. These drivers represent accounts that assess HUTCHMED DRC's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of HUTCHMED DRC's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.3B | 4.5B | 5.6B | 2.5B | 3.1B | 2.9B | |
| Enterprise Value | 3.2B | 4.3B | 5.2B | 2.2B | 2.9B | 2.0B |
HUTCHMED DRC Institutional Holders
Institutional Holdings refers to the ownership stake in HUTCHMED DRC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of HUTCHMED DRC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing HUTCHMED DRC's value.| Shares | M&g Investment Management Ltd | 2023-12-31 | 188.7 K | Baillie Gifford & Co Limited. | 2023-12-31 | 145 K | Amundi | 2023-12-31 | 135.2 K | D. E. Shaw & Co Lp | 2023-09-30 | 129.1 K | Junked Platinum Investment Management Ltd | 2023-12-31 | 127.3 K | Dekabank Deutsche Girozentrale | 2023-12-31 | 86.5 K | Renaissance Technologies Corp | 2023-12-31 | 82.3 K | Fidelity International Ltd | 2023-12-31 | 76 K | Hennion & Walsh Asset Management Inc | 2023-12-31 | 55.6 K | Schroder Investment Management Group | 2023-12-31 | 4.2 M | General Atlantic Llc | 2023-12-31 | 4 M |
HUTCHMED Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.01 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | (0.31) % | ||||
| Current Valuation | 30.64 B | ||||
| Shares Outstanding | 170.73 M | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 9.40 % | ||||
| Number Of Shares Shorted | 515.84 K | ||||
| Price To Earning | 335.94 X | ||||
| Price To Book | 4.18 X | ||||
| Price To Sales | 3.74 X | ||||
| Revenue | 838 M | ||||
| Gross Profit | (271.59 M) | ||||
| EBITDA | 25.53 M | ||||
| Net Income | 100.78 M | ||||
| Cash And Equivalents | 829.71 M | ||||
| Cash Per Share | 4.91 X | ||||
| Total Debt | 86.13 M | ||||
| Current Ratio | 3.18 X | ||||
| Book Value Per Share | 0.86 X | ||||
| Cash Flow From Operations | 219.26 M | ||||
| Short Ratio | 3.28 X | ||||
| Earnings Per Share | 0.60 X | ||||
| Target Price | 28.47 | ||||
| Number Of Employees | 1.99 K | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 3.23 B | ||||
| Total Asset | 1.28 B | ||||
| Retained Earnings | (870.87 M) | ||||
| Working Capital | 693.81 M | ||||
| Current Asset | 187.47 M | ||||
| Current Liabilities | 96.7 M | ||||
| Net Asset | 1.28 B |
About HUTCHMED DRC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze HUTCHMED DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HUTCHMED DRC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HUTCHMED DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out HUTCHMED DRC Piotroski F Score and HUTCHMED DRC Altman Z Score analysis. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.Note that the HUTCHMED DRC information on this page should be used as a complementary analysis to other HUTCHMED DRC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for HUTCHMED Stock analysis
When running HUTCHMED DRC's price analysis, check to measure HUTCHMED DRC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED DRC is operating at the current time. Most of HUTCHMED DRC's value examination focuses on studying past and present price action to predict the probability of HUTCHMED DRC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED DRC's price. Additionally, you may evaluate how the addition of HUTCHMED DRC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is HUTCHMED DRC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HUTCHMED DRC. If investors know HUTCHMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HUTCHMED DRC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.6 | Revenue Per Share 4.93 | Quarterly Revenue Growth 0.36 | Return On Assets 0.01 | Return On Equity 0.1465 |
The market value of HUTCHMED DRC is measured differently than its book value, which is the value of HUTCHMED that is recorded on the company's balance sheet. Investors also form their own opinion of HUTCHMED DRC's value that differs from its market value or its book value, called intrinsic value, which is HUTCHMED DRC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HUTCHMED DRC's market value can be influenced by many factors that don't directly affect HUTCHMED DRC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HUTCHMED DRC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.